Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience
An Bras Dermatol
.
2023 Mar-Apr;98(2):240-242.
doi: 10.1016/j.abd.2022.06.003.
Epub 2022 Dec 23.
Authors
Elçin Akdaş
1
,
Esra Adışen
2
,
Murat Orhan Öztaş
2
,
Ahmet Burhan Aksakal
2
,
Nilsel İlter
2
,
Ayla Gülekon
2
Affiliations
1
Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey. Electronic address: mdelcinakdas@gmail.com.
2
Department of Dermatology, Gazi University Faculty of Medicine, Ankara, Turkey.
PMID:
36567165
PMCID:
PMC9984690
DOI:
10.1016/j.abd.2022.06.003
No abstract available
Publication types
Case Reports
MeSH terms
Anti-Allergic Agents* / therapeutic use
Chronic Disease
Chronic Urticaria* / drug therapy
Humans
Omalizumab / therapeutic use
Treatment Outcome
Urticaria* / drug therapy
Substances
Omalizumab
Anti-Allergic Agents